BridgeMD
New treatment option for Gastric Adenocarcinoma
Official title Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer
ClinicalTrials.gov ID: NCT07029269
What this study is testing
- What it's testing
- This study aims to compare the effects of using prophylactic abdominal drainage tubes during Enhanced Recovery After Surgery (ERAS) in patients undergoing Laparoscopic Distal Gastrectomy (LDG) for gastric cancer through a multicenter non-inferiority randomized trial. The study is divided into two groups: 1.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients' age from 18 to 80 years old;
- Histopathologically confirmed gastric adenocarcinoma;
- Clinical tumor stage of cT1-4N0-3M0;
- Laparoscopic distal gastrectomy approach;
- ECOG score of 0-1;
You likely can't join if
- Patients with severe concurrent illness or comorbid diseases;
- Patients with severe pyloric obstruction, recurrent or remnant gastric cancer; 3. Patients with perforation, or undergoing emergency surgery; 4\...
See the full eligibility criteria
- Patients' age from 18 to 80 years old;
- Histopathologically confirmed gastric adenocarcinoma;
- Clinical tumor stage of cT1-4N0-3M0;
- Laparoscopic distal gastrectomy approach;
- ECOG score of 0-1;
- Written informed consent
- Patients with severe concurrent illness or comorbid diseases;
- Patients with severe pyloric obstruction, recurrent or remnant gastric cancer; 3. Patients with perforation, or undergoing emergency surgery; 4\. Patients with a history of radiotherapy; 5. Patients undergoing complex...
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
- Fuzhou, Fujian, China
- Lanzhou, Gansu, China
- Zhejiang, Hangzhou, China
- Xi'an, Xi'an City, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China; Fuzhou, Fujian, China; Lanzhou, Gansu, China; Zhejiang, Hangzhou, China; Xi'an, Xi'an City, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.